The C-Suite: How Biotech Improves the Standard of Care of Patients

Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech

In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Understanding Patients in the Emerging Market of Brazil

Date Posted: 11/10/2011
Size: 6.89MB
Length: 00:15:03
Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar Health

In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.